InsiderTrades.com logo
Could this Tiny Biotech End Disease Forever?
From Behind the Markets   |   Ad
Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.
Access my full "Cut & Paste" profit analysis now.
Kapil Agrawal net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Kapil Agrawal Biography and Net Worth

CFO of Poshmark
Kapil Agrawal is the Interim Chief Financial Officer of Poshmark, where he is responsible for the company’s overall financial strategy, including developing and implementing processes, forecasting, cash flow management, and investor relations. Previously, Kapil served as Vice President of Finance, Investor Relations, and Corporate Development at Poshmark. Prior to Poshmark, Kapil served as global head of pricing strategy and operations at Uber, where he guided the company’s overall growth and expansion into new products such as UberEATS and UberPOOL. Previously, Kapil served as head of business strategy for Capital One’s Home loans business. Kapil was also a management consultant with PwC, where he helped both fortune 500 companies and startups grow their topline and improve profitability. Kapil holds an M.B.A. from the Darden School of Business and a BS in Mechanical Engineering from the Indian Institute of Technology at Bombay.

What is Kapil Agrawal's net worth?

The estimated net worth of Kapil Agrawal is at least $1.35 million as of August 31st, 2021. Mr. Agrawal owns 75,480 shares of Poshmark stock worth more than $1,351,092 as of May 8th. This net worth estimate does not reflect any other assets that Mr. Agrawal may own. Learn More about Kapil Agrawal's net worth.

How do I contact Kapil Agrawal?

The corporate mailing address for Mr. Agrawal and other Poshmark executives is 203 REDWOOD SHORES PARKWAY 8TH FLOOR, REDWOOD CITY CA, 94065. Poshmark can also be reached via phone at 650-262-4771 and via email at [email protected]. Learn More on Kapil Agrawal's contact information.

Has Kapil Agrawal been buying or selling shares of Poshmark?

Kapil Agrawal has not been actively trading shares of Poshmark during the last ninety days. Most recently, Kapil Agrawal sold 2,342 shares of the business's stock in a transaction on Monday, October 4th. The shares were sold at an average price of $23.59, for a transaction totalling $55,247.78. Learn More on Kapil Agrawal's trading history.

Who are Poshmark's active insiders?

Poshmark's insider roster includes Kapil Agrawal (CFO), Manish Chandra (CEO), Anan Kashyap (CFO), John McDonald (COO), and Hans Tung (Director). Learn More on Poshmark's active insiders.

Kapil Agrawal Insider Trading History at Poshmark

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/4/2021Sell2,342$23.59$55,247.78View SEC Filing Icon  
9/2/2021Sell536$28.52$15,286.72View SEC Filing Icon  
8/31/2021Sell10,000$28.91$289,100.0075,480View SEC Filing Icon  
See Full Table

Kapil Agrawal Buying and Selling Activity at Poshmark

This chart shows Kapil Agrawal's buying and selling at Poshmark by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Poshmark Company Overview

Poshmark logo
Poshmark, Inc. operates as a social marketplace for new and secondhand style products in the United States, Canada, India, and Australia. The company offers apparel, footwear, home, beauty, and pet products, as well as accessories. As of December 31, 2021, it had 7.6 million active buyers. The company was formerly known as GoshPosh, Inc. and changed its name to Poshmark, Inc. in 2011. Poshmark, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Read More

Today's Range

Now: $17.90
Low: $17.90
High: $17.90

50 Day Range

MA: $17.82
Low: $17.72
High: $17.90

2 Week Range

Now: $17.90
Low: $8.97
High: $17.92

Volume

N/A

Average Volume

1,010,092 shs

Market Capitalization

$1.42 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Could this Tiny Biotech End Disease Forever?
From Behind the Markets   |   Ad
Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.
Access my full "Cut & Paste" profit analysis now.